-
1
-
-
0141919077
-
-
Chinese source
-
-
-
-
2
-
-
84975525035
-
Clinical application of research on angiogenesis
-
Folkman J. Clinical application of research on angiogenesis. New Engl J Med, 1995; 333(26): 1757
-
(1995)
New Engl J Med
, vol.333
, Issue.26
, pp. 1757
-
-
Folkman, J.1
-
3
-
-
0034009936
-
The clinical manipulation of angiogenesis: Pathology, side-effects, surprise and opportunities with novel human therapies
-
Thompson WD, William WL, Maragoudakis M, et al. The clinical manipulation of angiogenesis: pathology, side-effects, surprise and opportunities with novel human therapies. J Pathol, 2000; 190(3): 330
-
(2000)
J Pathol
, vol.190
, Issue.3
, pp. 330
-
-
Thompson, W.D.1
William, W.L.2
Maragoudakis, M.3
-
4
-
-
0141988140
-
-
Chinese source
-
-
-
-
5
-
-
0141988135
-
-
Chinese source
-
-
-
-
6
-
-
0028939826
-
Clinical importance of the determination of tumor angiogenesis in breast carcinoma; much more than a new prognostic tool
-
Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma; much more than a new prognostic tool. J Clin Oncol, 1995; 139(3): 765
-
(1995)
J Clin Oncol
, vol.139
, Issue.3
, pp. 765
-
-
Gasparini, G.1
Harris, A.2
-
7
-
-
0027970092
-
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma
-
O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell, 1994; 79(2): 315
-
(1994)
Cell
, vol.79
, Issue.2
, pp. 315
-
-
O'Reilly, M.S.1
Holmgren, L.2
Shing, Y.3
-
8
-
-
0032719528
-
Interferon alpha mediated down regulation of angiogenesis related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
-
Slaton JW, Perotte P, Inoue K, et al. Interferon alpha mediated down regulation of angiogenesis related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res, 1999; 5(10): 2726
-
(1999)
Clin Cancer Res
, vol.5
, Issue.10
, pp. 2726
-
-
Slaton, J.W.1
Perotte, P.2
Inoue, K.3
-
9
-
-
0031038068
-
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumour growth b1, platlet-derived endothelial cell growth factor, placental growth factor and pleiotrophin in human primary breast cancer and its relation to angiogenesis
-
Relf M, Lejeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumour growth b1, platlet-derived endothelial cell growth factor, placental growth factor and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res, 1997; 57(5): 963
-
(1997)
Cancer Res
, vol.57
, Issue.5
, pp. 963
-
-
Relf, M.1
Lejeune, S.2
Scott, P.A.3
-
10
-
-
0141953494
-
-
Chinese source
-
-
-
-
11
-
-
0029328266
-
Intratumor microvessel density as a prognostic factor in cancer
-
Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995; 147(1): 9
-
(1995)
Am J Pathol
, vol.147
, Issue.1
, pp. 9
-
-
Weidner, N.1
-
12
-
-
0029438099
-
Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1)
-
Fan ZN, Isobe K, Kiuchi K, et al. Enhancement of nitric oxide production from activated macrophages by a purified form of ginsenoside (Rg1). Am J Chin Med, 1995; 23(3-4): 279
-
(1995)
Am J Chin Med
, vol.23
, Issue.3-4
, pp. 279
-
-
Fan, Z.N.1
Isobe, K.2
Kiuchi, K.3
-
13
-
-
0025731492
-
Serum requirement for in vitro invasion by tumor cells
-
Imamura F, Horai T, Mukai M, et al. Serum requirement for in vitro invasion by tumor cells. Jpn J Cancer Res, 1991; 82 (5): 493
-
(1991)
Jpn J Cancer Res
, vol.82
, Issue.5
, pp. 493
-
-
Imamura, F.1
Horai, T.2
Mukai, M.3
|